Doylestown, PA, United States of America

Jeffery C Geesin


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jeffery C. Geesin - Innovator in Orthopedic Technology

Introduction

Jeffery C. Geesin, an innovative inventor based in Doylestown, PA, has made significant contributions to the field of orthopedic medicine. With his unique approach to treating joint diseases, he has secured a patent that showcases his expertise and dedication to improving patient outcomes.

Latest Patents

Jeffery holds a patent for the invention titled "Trans-capsular administration of p38 MAP kinase inhibitors into orthopedic joints." This innovative method relates to the trans-capsular delivery of an inhibitor of p38 MAP kinase or other therapeutic agents directly into diseased joints. This approach aims to enhance treatment efficacy for patients suffering from joint-related ailments.

Career Highlights

Currently, Jeffery is associated with DePuy Mitek, Inc., a renowned company in the healthcare sector focusing on orthopedic solutions. His role within the organization allows him to apply his innovative ideas and translate them into practical applications that benefit patients and healthcare providers alike.

Collaborations

Throughout his career, Jeffery has collaborated with notable coworkers, including Laura Brown and Carrie H. Fang. These partnerships contribute to a dynamic work environment where ideas can flourish, leading to groundbreaking advancements in orthopedic treatments.

Conclusion

Jeffery C. Geesin exemplifies the spirit of innovation in orthopedic technology. Through his patent and work at DePuy Mitek, Inc., he continues to pave the way for new treatment options that can significantly improve the quality of life for patients affected by joint diseases. His commitment to research and development in this field is commendable and inspires future inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…